Biotech Globalization Market Intelligence 
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 Sign up for your free trial today.
BIS Research
MARCH 19, 2019
As on date, the burgeoning economic burden due to the increasing incidence of chronic diseases, such as cancer is paving the way for precision medicine market. Precision medicine holds immense potential to transform the healthcare industry as it can help save the total global expenditure on curing and preventing chronic diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alpha Sense BI
APRIL 29, 2024
Market Intelligence at Scale : GenAI has the potential to securely pair a company’s internal content with leading premium market content sources using proprietary large language models (LLMs) and genAI trained on both business and financial content. The renewable energy sub-sector is also seeing promising activity.
Alpha Sense BI
APRIL 19, 2024
On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. In fact, projections for the global spatial computing market are valued at $269.8 In any case, this technology is one to watch—the global computing market is set to grow at a CAGR of 28.8%
Alpha Sense BI
MARCH 13, 2024
According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.
Alpha Sense BI
MARCH 28, 2023
The Value: AlphaSense is an AI-powered search engine for market intelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend.
Alpha Sense BI
JANUARY 25, 2023
Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Using the AlphaSense platform, we dug deep into new drug research and development areas that will likely shape the 2023 vaccine market. a potential cure for skin cancer.
Expert insights. Personalized for you.
96 
Let's personalize your content